ELIDEL / application site reactions
United States · event evidence
application site reactions
Listed
Reported as a primary reason for discontinuation due to adverse events in patients treated with ELIDEL Cream.
- Authority
- DailyMed, U.S. National Library of Medicine
- Document
- ELIDEL (PIMECROLIMUS) CREAM [PHYSICIANS TOTAL CARE, INC.]
- Jurisdiction
- United States
- Version / revision
- 1
- Document date
- Not recorded
Source evidence
Discontinuations for AEs were primarily due to application site reactions, and cutaneous infections.
- Section
- Not stated
- Context
- Reported as a primary reason for discontinuation due to adverse events in patients treated with ELIDEL Cream.
- Frequency
- Not stated
- Population / denominator
- Not stated
Return to label evidence explorer